Alpha Tau Medical Ltd. DRTS
Annual
Quarterly
No annual revenue total was found in Alpha Tau Medical Ltd.'s SEC filings.
Alpha Tau Medical Ltd. (DRTS) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. Free cash flow was -$32.8 million. As of Dec 31, 2025 it held $73.1 million in cash and investments and $7.4 million in total debt.
Revenue
—
Net income
$-42.63M
-34.3% vs prior year
Operating cash flow
$-26.68M
-34.9% vs prior year
Free cash flow
$-32.76M
-48.7% vs prior year
EPS
$-0.53
-17.8% vs prior year
Dividend per share
None
Shares outstanding
88.01M
+25.0% vs prior year
Net cash
$65.75M
FY 2025
Operating margin
—
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- DRTS (Nasdaq), DRTSW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Jerusalem, Israel
- SEC filer status
- Accelerated filer, Emerging growth company
- SEC CIK
- 1871321
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Operating income | -$42.3M | -$36.0M | -$35.7M | -$32.1M | -$13.8M |
| Net income | -$42.6M | -$31.8M | -$29.2M | -$33.8M | -$27.3M |
| Diluted EPS | -$0.53 | -$0.45 | -$0.42 | -$0.53 | -$0.67 |
| Operating cash flow | -$26.7M | -$19.8M | -$18.0M | -$23.9M | -$11.8M |
| Free cash flow | -$32.8M | -$22.0M | -$24.4M | -$24.8M | -$14.7M |
| Total assets | $105.7M | $86.2M | $107.4M | $120.1M | $42.2M |
| Total liabilities | $28.6M | $23.5M | $22.9M | $14.5M | $23.0M |
| Stockholders' equity | $77.1M | $62.7M | $84.5M | $105.7M | -$34.8M |
| Cash and investments | $73.1M | $59.6M | $81.8M | $104.5M | $23.2M |
| Total debt | $7.4M | $7.0M | $7.7M | $5.2M | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 29, 2026 | Oct 29, 2026 |
| 6-K | Current report (foreign issuer) | Oct 22, 2026 | Oct 22, 2026 |
| 6-K | Current report (foreign issuer) | Oct 19, 2026 | Oct 19, 2026 |
| 6-K | Current report (foreign issuer) | Aug 31, 2026 | Aug 31, 2026 |
| 6-K | Current report (foreign issuer) | Aug 10, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 10, 2026 | Aug 10, 2026 |
All 239 Alpha Tau Medical Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.